Creating a Multidisciplinary Hepatocellular Carcinoma Clinic Improves Survival

Forming a multidisciplinary clinic for patients with HCC resulted in improved survival, likely due to more streamlined care and earlier diagnosis, found research presented at SSO 2013.

Public Reporting of Individual Hospital Cancer-Specific Quality Metrics Recommended

Major challenges exist for hospitals with respect to publicly reported cancer metrics, according to research presented at SSO 2013.

Alvimopan Decreases Length of Stay, Treatment Costs, in Elective Bowel Resections

Adding alvimopan to an established fast-track enhanced recovery protocol significantly decreased length of stay and overall treatment cost in patients undergoing elective bowel resection for cancer, found research presented at SSO 2013.

Elevated Preoperative C-Reaction Protein Associated with Worse Survival in Patients Undergoing Palliative Procedures

Patients with advanced cancer who are less likely to benefit from palliative procedures often have elevated preoperative C-reaction protein, according to research presented at SSO 2013.

Similar Disease-Specific Survival Rates Reported for Pre- and Post-Surgical Ipilimumab for Stage 4 Melanoma

Disease-specific survival appears not to be significantly different between patients with stage 4 melanoma who are administered ipilimumab before surgical resection and those who receive ipilimumab therapy after surgery, according to research presented at SSO 2013.

FOLFIRINOX Shows Promise in Locally Advanced Pancreatic Cancer

Despite significant toxicity, the FOLFIRINOX chemotherapy regimen is associated with clinical responses among patients with locally advanced pancreatic ductal adenocarcinoma, according to research presented at SSO 2013.

Adding Sunitinib to Tamoxifen Shows Preclinical Promise for ER-Positive Breast Cancer

Adding sunitinib to tamoxifen antiestrogen therapy might prove to be a promising treatment strategy for estrogen receptor-positive breast cancer, according to research presented at SSO 2013.

Intraperitoneal and Intravenous Paclitaxel + Combination Chemotherapy Effective in Peritoneal Metastasis

Combination chemotherapy with S-1—oral tegafur, gimeracil, and oteracil potassium—and IV and intraperitoneal paclitaxel was well-tolerated and very effective in patients with gastric cancer and peritoneal metastasis, according to research presented at SSO 2013.

Sentinel Lymph Node Biopsy Versus Nodal Observation Improves Survival in Merkel Cell Carcinoma

Sentinel lymph node biopsy provides prognostic information and is independently associated with improved survival in patients with Merkel cell carcinoma, according to research presented at SSO 2013.

Genetic Recurrence Score Predicts Locoregional Risk in Node-Positive, ER-Positive Breast Cancer After Adjuvant Chemotherapy and Tamoxifen

A 21-gene recurrence risk score also predicts locoregional recurrence among patients with node-positive ER-positive breast cancer who are treated with adjuvant chemotherapy and tamoxifen, according to research presented at SSO 2013.

Rehospitalization for Complications is 'Common' Following Radiofrequency Tumor Ablation

Hospital readmissions within 30 days of discharge after tumor radiofrequency ablation treatments are common, according to research presented at SSO 2013.

Nomogram Models Predict Progression Risks for Pancreatic Cancer

Multivariate nomogram models predict patients' risks of progression of adenomas to high-grade dysplasia/carcinoma in situ and invasive carcinoma in main and branch-duct intraductal papillary mucinous neoplasms of the pancreas, according to research presented at SSO 2013.

Intra-Arterial Therapy Promising for Intrahepatic Chloangiocarcinoma

Intra-arterial therapy is associated with promising locoregional control rates among patients with intrahepatic chloangiocarcinoma, according to research presented at SSO 2013.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs